A NanoBRET target engagement assay for querying domain selectivity at full-length polymerase theta in live cells

被引：0
|
作者：
Edenson, Steven
Slater, Michael
Corona, Cesear
Beck, Michael
Vasta, James
Teske, Kelly
Michaud, Ani
Robers, Matthew
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3104
引用
收藏
页数：2
相关论文
共 30 条
  • [1] A live cell PRMT5 NanoBRET Target Engagement Assay querying competitive and uncompetitive modes of inhibition
    Michaud, Ani
    Rothweiler, Elisabeth
    Corona, Cesear
    Beck, Michael
    Wilkinson, Jennifer
    Vasta, James
    Huber, Kilian
    Robers, Matthew
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Exploring the landscape of PARP and PARG inhibitor selectivity in live cells using NanoBRET™ target engagement assays
    Michaud, Ani
    Teske, Kelly
    Wilkinson, Jennifer
    Zimprich, Chad
    Vasta, James
    Corona, Cesear
    Zhou, Min
    Dominguez, Elizabeth
    Dunn-Hoffman, Kaitlin
    Robers, Matthew
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Application of NanoBRET target engagement cellular assay for measurement of inhibitor binding to wild type and mutant RAS in live cells
    Wu, Jianghong
    McGinley, Shawn
    Wang, Yuan
    Gallagher, Peter
    Ma, Haiching
    CANCER RESEARCH, 2022, 82 (12)
  • [4] Endonuclease substrate selectivity characterized with full-length PA of influenza A virus polymerase
    Noble, Erin
    Cox, Andrew
    Deval, Jerome
    Kim, Baek
    VIROLOGY, 2012, 433 (01) : 27 - 34
  • [5] Development of Cell Permeable NanoBRET Probes for the Measurement of PLK1 Target Engagement in Live Cells
    Yang, Xuan
    Smith, Jeffery L.
    Beck, Michael T.
    Wilkinson, Jennifer M.
    Michaud, Ani
    Vasta, James D.
    Robers, Matthew B.
    Willson, Timothy M.
    MOLECULES, 2023, 28 (07):
  • [6] A live cell PRMT5 NanoBRETT target engagement assay querying competitive and uncompetitive modes of inhibition
    Teske, Kelly A.
    Michaud, Ani
    Rothweiler, Elisabeth
    Corona, Cesear
    Hoffman, Kaitlin Dunn
    Wilkinson, Jennifer
    Beck, Michael
    Vasta, James
    Huber, Kilian
    Robers, Matthew
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (06)
  • [7] Marker-free characterization of full-length transcriptomes of single live circulating tumor cells
    Poonia, Sarita
    Goel, Anurag
    Chawla, Smriti
    Bhattacharya, Namrata
    Rai, Priyadarshini
    Lee, Yi Fang
    Yap, Yoon Sim
    West, Jay
    Bhagat, Ali Asgar
    Tayal, Juhi
    Mehta, Anurag
    Ahuja, Gaurav
    Majumdar, Angshul
    Ramalingam, Naveen
    Sengupta, Debarka
    GENOME RESEARCH, 2023, 33 (01) : 80 - 95
  • [8] Full-length knows better: Substrate selectivity of the protease domain of urokinase-type plasminogen activator (uPA)
    Torres-Paris, Constanza
    Song, Harriet J.
    Komives, Elizabeth A.
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 355A - 355A
  • [9] The preferential transport of NO3-by full-length Guillardia theta anion channelrhodopsin 1 is enhanced by its extended cytoplasmic domain
    Ohki, Yuya
    Shinone, Tsukasa
    Inoko, Sayo
    Sudo, Miu
    Demura, Makoto
    Kikukawa, Takashi
    Tsukamoto, Takashi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (11)
  • [10] Fluorescently tagged nanobodies and NanoBRET to study ligand-binding and agonist-induced conformational changes of full-length EGFR expressed in living cells
    Comez, Dehan
    Glenn, Jacqueline
    Anbuhl, Stephanie M. M.
    Heukers, Raimond
    Smit, Martine J. J.
    Hill, Stephen J. J.
    Kilpatrick, Laura E. E.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
123